STERIS Dirección

Dirección controles de criterios 4/4

El CEO de STERIS' es Dan Carestio , nombrado en Jul 2021, tiene una permanencia de 2.75 años. compensación anual total es $7.74M, compuesta por 12.5% salario y 87.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.048% de las acciones de la empresa, por valor de $9.68M. La antigüedad media del equipo directivo y de la junta directiva es de 4.2 años y 7.2 años, respectivamente.

Información clave

Dan Carestio

Chief Executive Officer (CEO)

US$7.7m

Compensación total

Porcentaje del salario del CEO	12.5%
Permanencia del CEO	2.8yrs
Participación del CEO	0.05%
Permanencia media de la dirección	4.3yrs
Promedio de permanencia en la Junta Directiva	7.3yrs

Actualizaciones recientes de la dirección

Recent updates

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Dec 17

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Nov 24

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Nov 06

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Sep 18

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

When Should You Buy STERIS plc (NYSE:STE)?

Aug 10

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Feb 01

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Dec 28

Steris declares $0.47 dividend

Nov 02

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Nov 01

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

Aug 18

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Aug 04

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Aug 02

Is STERIS (NYSE:STE) A Risky Investment?

Jul 19

Steris: Deleveraging Key Undercurrent, Valuation A Concern

Jun 12

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Apr 08

Steris: Another Essential Healthcare Supply Resource

Feb 01

Is STERIS (NYSE:STE) A Risky Investment?

Dec 15

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Dan Carestio en comparación con los beneficios de STERIS?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	US$567m
Sep 30 2023	n/a	n/a	US$550m
Jun 30 2023	n/a	n/a	US$119m
Mar 31 2023	US$8m	US$970k	US$107m
Dec 31 2022	n/a	n/a	-US$28m
Sep 30 2022	n/a	n/a	-US$8m
Jun 30 2022	n/a	n/a	US$377m
Mar 31 2022	US$6m	US$767k	US$244m
Dec 31 2021	n/a	n/a	US$279m
Sep 30 2021	n/a	n/a	US$250m
Jun 30 2021	n/a	n/a	US$286m
Mar 31 2021	US$3m	US$542k	US$397m
Dec 31 2020	n/a	n/a	US$433m
Sep 30 2020	n/a	n/a	US$424m
Jun 30 2020	n/a	n/a	US$413m
Mar 31 2020	US$2m	US$522k	US$408m
Dec 31 2019	n/a	n/a	US$393m
Sep 30 2019	n/a	n/a	US$336m
Jun 30 2019	n/a	n/a	US$319m
Mar 31 2019	US$2m	US$482k	US$304m
Dec 31 2018	n/a	n/a	US$269m
Sep 30 2018	n/a	n/a	US$316m
Jun 30 2018	n/a	n/a	US$303m
Mar 31 2018	US$1m	US$379k	US$291m

Compensación vs. Mercado: La compensación total de Dan($USD7.74M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD13.51M).

Compensación vs. Ingresos: La compensación de Dan ha sido consistente con los resultados de la empresa en el último año.

CEO

Dan Carestio (50 yo)

2.8yrs

Permanencia

US$7,740,184

Compensación

Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Daniel Carestio	President	2.8yrs	US$7.74m	0.048% $ 9.6m
Michael Tokich	Senior VP & CFO	16.2yrs	US$2.89m	0.047% $ 9.4m
John Zangerle	Senior VP	10.8yrs	US$2.26m	0.031% $ 6.2m
Mary Fraser	SVP & Chief Human Resources Officer	3.8yrs	US$1.48m	0.0094% $ 1.9m
Cary Majors	Senior Vice President & President of Healthcare	4.8yrs	US$1.59m	0.014% $ 2.7m
Karen Burton	Chief Accounting Officer	16yrs	sin datos	0.0068% $ 1.4m
Julie Winter	Vice President of Investor Relations & Corporate Communications	no data	sin datos	sin datos
Julia Madsen	Senior Vice President of Life Sciences	3.8yrs	sin datos	0.0086% $ 1.7m
Andrew Xilas	Senior VP & GM of Dental	2.9yrs	US$1.92m	0.0066% $ 1.3m
Kenneth Kohler	Senior VP & GM of AST	no data	sin datos	0.0022% $ 452.8k
Renato Tamaro	VP & Corporate Treasurer	6.8yrs	sin datos	0.0068% $ 1.4m
Walter Rosebrough	CEO Emeritus & Senior Advisor	2.8yrs	US$1.16m	sin datos

4.3yrs

Permanencia media

54.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de STE se considera experimentado (4.2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Daniel Carestio	President	3.3yrs	US$7.74m	0.048% $ 9.6m
Richard Breeden	Independent Director	16.1yrs	US$345.80k	0.028% $ 5.7m
Mohsen Sohi	Independent Chairman of the Board	18.8yrs	US$464.87k	0.023% $ 4.6m
Jacqueline Kosecoff	Independent Director	20.6yrs	US$340.81k	0.027% $ 5.4m
Cynthia Feldmann	Independent Director	19.2yrs	US$341.82k	0.0095% $ 1.9m
Richard Steeves	Independent Director	8.5yrs	US$341.81k	0% $ 0
Paul Martin	Independent Director	3yrs	US$328.34k	sin datos
Nirav Shah	Independent Director	6yrs	US$328.30k	0.00030% $ 60.6k
Christopher Holland	Independent Director	3.8yrs	US$334.34k	0.000070% $ 14.1k
Esther Alegria	Independent Director	less than a year	sin datos	sin datos

7.3yrs

Permanencia media

64.5yo

Promedio de edad

Junta con experiencia: La junta directiva de STE se considera experimentada (7.2 años de antigüedad promedio).

STERIS Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc, Annual General Meeting, Jul 27, 2023

Independent Director recently sold US$578k worth of stock

Independent Director exercised options and sold US$785k worth of stock

Insider recently sold US$219k worth of stock

Independent Director exercised options to buy US$863k worth of stock.

Recent updates

STERIS plc Announces Quarterly Interim Dividend, Payable on June 26, 2024

STERIS plc to Report Q4, 2024 Results on May 08, 2024

Steris: Moving On, Losing Its Teeth

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Upcoming dividend of US$0.52 per share at 0.9% yield

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

STERIS plc Revises Financial Guidance for the Fiscal Year 2024

Second quarter dividend of US$0.52 announced

STERIS plc Announces Quarterly Interim Dividend, Payable on March 22, 2024

Now 21% undervalued

STERIS plc to Report Q3, 2024 Results on Feb 07, 2024

Now 20% undervalued

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Upcoming dividend of US$0.52 per share at 1.0% yield

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

STERIS plc Confirms Earnings Guidance for the Fiscal Year 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

STERIS plc Announces Quarterly Interim Dividend, Payable on December 21, 2023

STERIS plc to Report Q2, 2024 Results on Nov 07, 2023

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Upcoming dividend of US$0.52 per share at 0.9% yield

When Should You Buy STERIS plc (NYSE:STE)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

STERIS plc Appoints Dr. Esther Alegria to Serve on the Compliance and Technology Committee and the Nominating and Governance Committee of the Board

STERIS plc to Report Q1, 2024 Results on Aug 01, 2023

Steris: Continuing To Grow The Product Lineup

STERIS plc, Annual General Meeting, Jul 27, 2023

Upcoming dividend of US$0.47 per share at 0.9% yield

Independent Director recently sold US$578k worth of stock

Independent Director exercised options and sold US$785k worth of stock

STERIS plc Provides Revenue Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

STERIS plc (NYSE:STE) announces an Equity Buyback for $500 million worth of its shares.

Insider recently sold US$219k worth of stock

Independent Director exercised options to buy US$863k worth of stock.

Upcoming dividend of US$0.47 per share at 0.9% yield

Third quarter 2023 earnings: Revenues miss analyst expectations

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

STERIS plc Updates Financial Guidance for the Fiscal Year Ending March 31, 2023

STERIS plc Declares Quarterly Interim Dividend, Payable on March 23, 2023

Steris declares $0.47 dividend

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

STERIS plc to Report Q3, 2023 Results on Feb 08, 2023

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Insider recently sold US$308k worth of stock

Upcoming dividend of US$0.47 per share

STERIS plc Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings: Revenues miss analyst expectations

STERIS plc Declares Interim Dividend, Payable on December 16, 2022

Steris declares $0.47 dividend

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Price target decreased to US$230

STERIS plc to Report Q2, 2023 Results on Nov 09, 2022

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Upcoming dividend of US$0.47 per share

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

First quarter 2023 earnings: EPS and revenues miss analyst expectations

STERIS plc Provides Revenue Guidance for Fiscal 2023

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Steris plc Declares Quarterly Interim Dividend, Payable on September 23, 2022

STERIS plc to Report Q1, 2023 Results on Aug 02, 2022